Preventing Relapse of Problem Behavior Through Behavioral Economics: A Translational Analysis
Launched by OAKLAND UNIVERSITY · Oct 18, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method to help reduce problem behaviors in children and young adults who have intellectual and developmental disabilities. The researchers want to see if a specific type of training, called "progressive ratio training," is more effective than the usual care currently provided. They are looking at two main questions: how well this new method can prevent people from returning to problem behaviors when they are prompted to do so (response-dependent reinstatement), and how well it can help when behaviors might occur without any specific prompts (response-independent reinstatement).
The trial is open to boys and girls aged 6 to 21 who show problem behaviors and have a diagnosis of an intellectual or developmental disability. Participants can expect to take part in training sessions aimed at reducing these behaviors, and their progress will be closely monitored. If you or someone you know fits this description and is interested in participating, this trial could provide an opportunity to explore a new approach to managing problem behaviors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Boys and girls from ages 6 to 21
- • Engage in problem behavior
- • Diagnosis of some type of intellectual and developmental disability
- Exclusion Criteria:
- • Not meeting the inclusion criteria
About Oakland University
Oakland University is a distinguished clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative studies. Based in Rochester, Michigan, the university fosters a collaborative environment that integrates academic rigor with practical application, engaging multidisciplinary teams of researchers, healthcare professionals, and students. Committed to ethical standards and regulatory compliance, Oakland University focuses on a diverse range of clinical trials that address pressing health challenges, aiming to contribute valuable insights to the scientific community and enhance therapeutic options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Michigan, United States
Auburn, Alabama, United States
Patients applied
Trial Officials
Michael P Kranak, PhD
Principal Investigator
Oakland University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported